Covered recipient · General Payments record
TAYLOR HALLENBECK
General Payments · PY2021–2024
$2,885.97
- Reported across 146 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,406.62 | 59 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | $213.76 | 3 |
| UCB, Inc. | $180.20 | 7 |
| Neurocrine BioSciences, Inc. | $175.93 | 9 |
| Lilly USA, LLC | $87.53 | 5 |
| Lundbeck LLC | $82.45 | 3 |
| SK Life Science, Inc. | $62.60 | 2 |
| EISAI INC. | $59.76 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $45.61 | 2 |
| Alexion Pharmaceuticals, Inc. | $39.94 | 2 |
| ABBVIE INC. | $38.65 | 2 |
| MDD US Operations, LLC | $36.09 | 1 |
| PFIZER INC. | $31.45 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.49 | 2 |
| Xeris Pharmaceuticals, Inc. | $24.63 | 1 |
| Marinus Pharmaceuticals, Inc. | $23.97 | 1 |
| Otsuka America Pharmaceutical, Inc. | $23.00 | 1 |
| Janssen Pharmaceuticals, Inc | $22.93 | 1 |
| ARGENX US, INC. | $22.89 | 1 |
| Neurelis, Inc. | $20.68 | 1 |
| Octapharma USA, Inc. | $20.19 | 1 |
| JAZZ PHARMACEUTICALS INC. | $19.43 | 1 |
| ANI Pharmaceuticals, Inc. | $18.87 | 1 |
| Vanda Pharmaceuticals Inc. | $17.93 | 1 |
| Biogen, Inc. | $17.55 | 1 |
| ACADIA Pharmaceuticals Inc | $16.43 | 1 |
| Genentech USA, Inc. | $16.05 | 1 |
| Acerta Pharma LLC | $15.37 | 1 |
| Amgen Inc. | $14.74 | 1 |
| Amneal Pharmaceuticals LLC | $14.02 | 1 |
| EMD Serono, Inc. | $13.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (59)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.